gary breca bpc 157 Ben Carpenter | This video isn't about Brecka. Not strictly, anyway. I randomly stumbled across this video where Gary Brecka is asked for his Gary Brecka: Human Biologist on

Simple, transparent pricing One plan

BPC-157 has accumulated an impressive safety profile in animal studies

Ods.od.nih.gov

human clinical trials ongoing as of 2026 Search volume: 165,000 monthly US searches most searched non-weight-loss peptide Legal status: Category 1 compounding (legal under physician prescription, as of February 2026) Administration: Subcutaneous injection or oral/sublingual (gut applications) An honest note on the evidence: The majority of BPC-157 research has been conducted in animal models rats and mice primarily

Vials should be kept sealed when not in active use, and standard aseptic technique is recommended to maintain sample integrity across a research timeline

Since it does not affect hormone levels, insulin sensitivity, or appetite regulation, there is no rebound effect from discontinuation